EVALUATION OF 2 INTRAVENOUS THROMBOLYTIC AGENTS (ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS STREPTOKINASE) IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

被引：5
|
作者：
SEABRAGOMES, R
SILVA, JA
ALEIXO, A
REAL, T
FREIRE, I
TORRES, I
FREITAS, R
CRESPO, F
机构：
来源：
DRUGS | 1987年 / 33卷
关键词：
D O I：
10.2165/00003495-198700333-00028
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：169 / 174
页数：6
相关论文
共 50 条
  • [41] SYSTEMIC EFFECTS OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX AND STREPTOKINASE THERAPY IN ACUTE MYOCARDIAL-INFARCTION - COAGULATION ASPECTS OF THE DUTCH INVASIVE REPERFUSION STUDY
    HOFFMANN, JJML
    BONNIER, JJRM
    DESWART, JBRM
    CUSTERS, P
    VIJGEN, M
    DRUGS, 1987, 33 : 242 - 246
  • [42] EFFECT OF REPERFUSION ON ELECTROCARDIOGRAPHIC AND ENZYMATIC INFARCT SIZE - RESULTS OF A RANDOMIZED MULTICENTER STUDY OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) VERSUS INTRACORONARY STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION
    HACKWORTHY, RA
    SORENSEN, SG
    FITZPATRICK, PG
    BARRY, WH
    MENLOVE, RL
    ROTHBARD, RL
    ANDERSON, JL
    AMERICAN HEART JOURNAL, 1988, 116 (04) : 903 - 914
  • [43] CLINICAL EFFECTS AND KINETIC-PROPERTIES OF INTRAVENOUS APSAC - ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (BRL 26921) IN ACUTE MYOCARDIAL-INFARCTION
    BEEN, M
    DEBONO, DP
    MUIR, AL
    BOULTON, FE
    FEARS, R
    STANDRING, R
    FERRES, H
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1986, 11 (01) : 53 - 61
  • [44] A PLACEBO-CONTROLLED PATENCY STUDY OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX-30U IN ACUTE MYOCARDIAL-INFARCTION
    DEBONO, DP
    DRUGS, 1987, 33 : 138 - 139
  • [45] REOCCLUSION 3 MONTHS AFTER SUCCESSFUL THROMBOLYTIC TREATMENT OF ACUTE MYOCARDIAL-INFARCTION WITH ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATING COMPLEX
    TAKENS, BH
    BRUGEMANN, J
    VANDERMEER, J
    DENHEIJER, P
    LIE, KI
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (22): : 1422 - 1424
  • [46] A SYSTEMIC NON-LYTIC STATE AND LOCAL THROMBOLYTIC FAILURE OF ANISTREPLASE (ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX, APSAC) IN ACUTE MYOCARDIAL-INFARCTION
    BRUGEMANN, J
    VANDERMEER, J
    TAKENS, BH
    HILLEGE, H
    LIE, KI
    BRITISH HEART JOURNAL, 1990, 64 (06): : 355 - 358
  • [47] ACYLATED STREPTOKINASE PLASMINOGEN COMPLEX IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    WALKER, ID
    DAVIDSON, JF
    RAE, AP
    HUTTON, I
    LAWRIE, TDV
    THROMBOSIS AND HAEMOSTASIS, 1984, 51 (02) : 204 - 206
  • [48] EFFICACY AND SAFETY OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE COMPLEX IN 50 PATIENTS WITH A 1ST MYOCARDIAL-INFARCTION
    BEEN, M
    DEBONO, DP
    MCLEOD, D
    MUIR, AL
    BOULTON, FE
    CIRCULATION, 1985, 72 (04) : 56 - 56
  • [49] SAFETY AND TOLERANCE DATA FROM THE BELGIAN MULTICENTER STUDY OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
    BOSSAERT, LL
    DRUGS, 1987, 33 : 287 - 292
  • [50] ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) IN ACUTE MYOCARDIAL-INFARCTION - RESULTS OF A MULTICENTER DOUBLE-BLIND TRIAL VERSUS HEPARIN
    CASSAGNES, J
    BASSAND, JP
    MACHECOURT, J
    LUSSON, JR
    ANGUENOT, T
    BOREL, E
    VACHER, D
    DENIS, B
    MAURAT, JP
    JALLUT, H
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1990, 83 (04): : 453 - 460
12345